Search
for

    Glossary Upadacitinib

    medication that inhibits enzymes to treat autoimmune conditions

    Upadacitinib is a medication that belongs to a class of drugs known as Janus kinase (JAK) inhibitors. It works by blocking specific enzymes involved in the inflammatory process, making it useful for treating autoimmune conditions like rheumatoid arthritis and, more recently, certain types of alopecia (hair loss).

    Research 10 of 287

    1. Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review Acta Dermato Venereologica · 2023 · 14 citations
    2. Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report Journal of the European Academy of Dermatology and Venereology · 2023 · 12 citations
    3. Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report SAGE Open Medical Case Reports · 2023 · 10 citations
    4. Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata Dermatology and therapy · 2023 · 9 citations
    5. Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study Clinical and Experimental Dermatology · 2024 · 7 citations
    6. Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report SAGE open medical case reports · 2022 · 7 citations
    7. Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study Journal of the American Academy of Dermatology · 2023 · 6 citations
    8. Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review Reumatismo · 2024 · 5 citations
    9. Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib Frontiers in Immunology · 2024 · 5 citations
    10. Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient Journal of Allergy and Clinical Immunology Global · 2024 · 5 citations
    All research results →

    Community 1

    1. Drug restored full hair in 23% and over 80% of hair in 55% in 6 months Reddit · 31 Aug 2026

    Learn

    — no results

    Try a deeper search in learn →